Diabetes, Obesity and Metabolism, 1462-8902

Journal

More filtering options
  1. 2020
  2. Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden

    Sofie Persson, Pierre Johansen, Emelie Andersson, Peter Lindgren, Desirée Thielke, Brian L. Thorsted, Johan Jendle & Katarina Steen Carlsson, 2020 Apr 24, In : Diabetes, Obesity and Metabolism.

    Research output: Contribution to journalArticle

  3. Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes

    Wathik Alsalim, Olga Göransson, Andrea Tura, Giovanni Pacini, Andrea Mari & Bo Ahrén, 2020 Apr, In : Diabetes, Obesity and Metabolism. 22, 4, p. 590-598 9 p.

    Research output: Contribution to journalArticle

  4. 2019
  5. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study

    Andrea Natali, Lorenzo Nesti, Elena Venturi, Angela C. Shore, Faisel Khan, Kim Gooding, Phillip E. Gates, Helen C. Looker, Fiona Dove, Isabel Goncalves, Margaretha Persson, Jan Nilsson & The SUMMIT consortium The SUMMIT consortium, 2019 Feb, In : Diabetes, Obesity and Metabolism. 21, 2, p. 412-416

    Research output: Contribution to journalArticle

  6. Investigating optimal β-cell-preserving treatment in latent autoimmune diabetes in adults: Results from a 21-month randomized trial

    Ingrid K. Hals, Hanne Fiskvik Fleiner, Nina Reimers, Marianne C. Astor, Karin Filipsson, Zuheng Ma, Valdemar Grill & Anneli Björklund, 2019, In : Diabetes, Obesity and Metabolism. 21, 10, p. 2219-2227

    Research output: Contribution to journalArticle

  7. 2018
  8. MicroRNAs in islet hormone secretion

    Jonathan L.S. Esguerra, Mototsugu Nagao, Jones K. Ofori, Anna Wendt & Lena Eliasson, 2018 Sep 1, In : Diabetes, Obesity and Metabolism. 20, Suppl 2, p. 11-19

    Research output: Contribution to journalReview article

  9. Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

    Bo Ahrén, Stephen L. Atkin, Guillaume Charpentier, Mark L. Warren, John P.H. Wilding, Sune Birch, Anders Gaarsdal Holst & Lawrence A. Leiter, 2018 Sep 1, In : Diabetes, Obesity and Metabolism. 20, 9, p. 2210-2219 10 p.

    Research output: Contribution to journalArticle

  10. Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects

    Wathik Alsalim, Olga Göransson, Richard D. Carr, Roberto Bizzotto, Andrea Tura, Giovanni Pacini, Andrea Mari & Bo Ahrén, 2018 Apr, In : Diabetes, Obesity and Metabolism. 20, 4, p. 1080-1085

    Research output: Contribution to journalArticle

  11. Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review

    Ian Pearce, Rafael Simó, Monica Lövestam-Adrian, David T. Wong & Marc Evans, 2018, In : Diabetes, Obesity and Metabolism.

    Research output: Contribution to journalReview article

  12. 2017
  13. Alain Ktorza, PhD

    Bernard Thorens, Domenico Accili, Bo Ahrén, Christian Boitard, Susumu Seino & Erol Cerasi, 2017 Sep 7, In : Diabetes, obesity & metabolism. 19, S1, p. 3-3 1 p.

    Research output: Contribution to journalDebate/Note/Editorial

  14. Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial

    Daisuke Yabe, Takashi Eto, Masanari Shiramoto, Shin Irie, Kenta Murotani, Yusuke Seino, Hitoshi Kuwata, Takeshi Kurose, Susumu Seino, Bo Ahrén & Yutaka Seino, 2017, In : Diabetes, Obesity and Metabolism. 19, 3, p. 442-447

    Research output: Contribution to journalArticle

  15. Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes

    David Preiss, Adem Dawed, Paul Welsh, Alison Heggie, Angus G. Jones, Jacqueline Dekker, Robert Koivula, Tue H. Hansen, Caitlin Stewart, Rury R. Holman, Paul W. Franks, Mark Walker, Ewan R. Pearson & Naveed Sattar, 2017, In : Diabetes, Obesity and Metabolism. 19, 3, p. 356-363

    Research output: Contribution to journalArticle

  16. 2016
  17. Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.

    Wathik Alsalim, Andrea Tura, Giovanni Pacini, Bilal Omar, Roberto Bizzotto, Andrea Mari & Bo Ahrén, 2016, In : Diabetes, Obesity and Metabolism. 18, 1, p. 24-33

    Research output: Contribution to journalArticle

  18. 2015
  19. The Islet and Metabolism Keep Time

    B. Thorens, D. Accili, Bo Ahrén, E. Cerasi, S. Seino & C. Boitard, 2015, In : Diabetes, Obesity and Metabolism. 17, Suppl 1, p. 3-5

    Research output: Contribution to journalDebate/Note/Editorial

  20. 2014
  21. Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.

    Bo Ahrén, Jean-Francois Gautier, Rachele Berria, William Stager, Ronnie Aronson & Cliff J Bailey, 2014, In : Diabetes, Obesity and Metabolism. 16, 9, p. 861-868

    Research output: Contribution to journalArticle

  22. The mind and the belly: a glance at how the nervous system directs metabolism

    D. Accili, Bo Ahrén, C. Boitard, S. Seino, B. Thorens & E. Cerasi, 2014, In : Diabetes, Obesity and Metabolism. 16, p. 1-3

    Research output: Contribution to journalDebate/Note/Editorial

  23. 2013
  24. Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

    M. Monami, Bo Ahrén, I. Dicembrini & E. Mannucci, 2013, In : Diabetes, Obesity and Metabolism. 15, 2, p. 112-120

    Research output: Contribution to journalArticle

  25. Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.

    Lena Ohlsson, Wathik Alsalim, Richard D Carr, Andrea Tura, Giovanni Pacini, Andrea Mari & Bo Ahrén, 2013, In : Diabetes, Obesity and Metabolism. 15, 6, p. 531-537

    Research output: Contribution to journalArticle

  26. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

    M. Nauck, Anders Frid, K. Hermansen, A. B. Thomsen, M. During, N. Shah, T. Tankova, I. Mitha & D. R. Matthews, 2013, In : Diabetes, Obesity and Metabolism. 15, 3, p. 204-212

    Research output: Contribution to journalArticle

  27. Shifting the paradigm of islet inflammation-good guy or bad guy?

    Bo Ahrén, D Accili, C Boitard, E Cerasi, B Thorens & S Seino, 2013, In : Diabetes, Obesity and Metabolism. 15, p. 4-9

    Research output: Contribution to journalDebate/Note/Editorial

  28. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

    M. Alba, Bo Ahrén, S. E. Inzucchi, Y. Guan, M. Mallick, L. Xu, E. A. O'Neill, D. E. Williams-Herman, K. D. Kaufman & B. J. Goldstein, 2013, In : Diabetes, Obesity and Metabolism. 15, 12, p. 1101-1110

    Research output: Contribution to journalArticle

  29. 2012
Previous 1 2 3 Next